Posted on 04/18/2026 10:33:26 AM PDT by UnwashedPeasant
A new observational study of 197 cancer patients taking a combined ivermectin + mebendazole protocol is going viral on social media — and for understandable reasons. At six-month follow-up, 84.4% of respondents reported clinical benefit (no evidence of disease, regression, or stable disease), and nearly half (48.4%) reported either tumor regression or no current evidence of disease. The combination was well tolerated, with only mild, mostly gastrointestinal side effects. The paper, posted on Zenodo about a week and a half ago, is the largest structured real-world look at this specific repurposed-drug pairing published to date.
This post is a summary. The full study is here: https://zenodo.org/records/19455636
The study was led by Nicolas Hulscher, MPH of the McCullough Foundation, with co-authors including Peter A. McCullough, MD, MPH, Harvey Risch, MD, PhD of the Yale School of Public Health, and Dr. Drew Pinsky — names many readers will recognize from the COVID era. That matters because it tells you where the paper sits: this is the same network of physicians and researchers that pushed early on repurposed-drug approaches during the pandemic, now turning the same lens on oncology.
The cohort skewed older (mean age 67) and covered prostate, breast, lung, colon, pancreatic, liver, and several other cancers. Patients took compounded capsules containing 25 mg ivermectin and 250 mg mebendazole, typically 1–2 per day. Adherence was high: 86.9% finished the initial 90-capsule course and 66.4% were still on protocol at six months. Many patients were also receiving standard care — chemotherapy (27.9%), radiation (21.3%), or surgery (19.7%) — alongside supplements and dietary changes.
The authors are clear about the caveats: outcomes were self-reported, there was no control group, all authors are affiliated with The Wellness Company (which prescribes, dispenses, and sells the protocol via telemedicine to all 50 states), and the paper is a preprint, not peer-reviewed. They describe the findings as "hypothesis-generating" and call for randomized, placebo-controlled trials.
Still, the signal is large enough, and the drugs cheap and safe enough, that it's worth reading the original rather than relying on social-media takes. Link above.
Shame Trump endorsed Ivermectin, it was the kiss of death for a lot of research.
Dunno if you are spun up on this or not. There is an active effort by Big Pharma and paid off doctors to demonize and ban the use of ivermectin. Alberta outlawed it outright.
A lot of corruption going on.
“Ivermectin is now a “horse paste”? And mebendazole a “dog wormer”?
Either you are trolling, or you are very dumb.”
The poster is correct, YOU are wrong.
“I am taking ivermectin + fenbendazole to treat stage 4 pancreatic cancer in conjunction with chemotherapy. It works.”
The cancer has both stabilized and reduced. Condolences on your feiend’s passing.
Since there was no control group, what was "the signal"?
The purpose of the control group is to measure the signal by comparing the outcomes and having a large enough population to reduce the effects of uncontrolled variables.
What are we to assume about "the signal"?
Thanks for the Ping!
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.